ライフサイエンスコーパス: anticardiolipin

1 oprotein 1 (beta2GP1), the target antigen of anticardiolipin.

2 including lupus anticoagulants (LAC) and/or anticardiolipin Ab (aCL), and thrombosis is recognized a

3 smatch (P = .003), positive test results for anticardiolipin (ACA) IgG (P = .03) or antiparietal anti

4 Pretransplant plasma anticardiolipin (aCL) and antiphosphatidylethanolamine (

5 Immunoglobulin G (IgG) anticardiolipin (aCL) antibodies are associated with val

6 The association of anticardiolipin (aCL) antibodies with coronary artery di

7 Anticardiolipin (aCL) autoantibodies are associated with

8 The dependence of anticardiolipin (aCL) binding on the presence of beta 2-

9 s were screened for IgG and IgM aPL using an anticardiolipin (aCL) enzyme-linked immunosorbent assay.

10 The anticardiolipin (aCL) test has been widely used by physi

11 alpha-PC) and beta2-glycoprotein-1-dependent anticardiolipin (alpha-CL), and these antibodies may lin

12 Sera were tested for anticardiolipin and anti-Sm/RNP antibodies.

13 tes developed antinuclear autoantibodies and anticardiolipin and anti-ssDNA antibodies.

14 smic, antiendothelial cell, antiphospholipid/anticardiolipin and antithyroid antibodies) are used whe

15 had positive results of lupus anticoagulant, anticardiolipin, and anti-beta(2)-glycoprotein I antibod

16 triple positivity (for lupus anticoagulant, anticardiolipin, and anti-beta2GPI antibodies) and recur

17 i-double-stranded DNA (anti-dsDNA), anti-Sm, anticardiolipin, and anti-ribosomal P autoantibodies and

18 Anticardiolipin (anti-CL) antibodies, diagnostic for ant

19 uld be proposed in men, aged >40 years, with anticardiolipin antibodies >60 GPLU when TTE is inconclu

20 Positive anticardiolipin antibodies (>22 immunoglobulin G-type ph

21 Recently, anticardiolipin antibodies (ACA) have been linked with c

22 e (APAS) is characterized by the presence of anticardiolipin antibodies (ACA) in association with thr

23 Antiphospholipid antibodies, including anticardiolipin antibodies (ACA), are strongly associate

24 trongly that lupus anticoagulants (LACs) and anticardiolipin antibodies (ACAs) are antibodies to prot

25 lls treated with a range of human monoclonal anticardiolipin antibodies (aCL) (as anti-beta2-glycopro

26 Yet, standard anticardiolipin antibodies (aCL) immunoassays routinely

27 anti-beta2-glycoprotein I (anti-beta2GPI) or anticardiolipin antibodies (aCL) may be implicated in th

28 Mice infused with IgG containing human anticardiolipin antibodies (aCL) were treated with IVIG

29 Anti-MDA-LDL, anticardiolipin antibodies (aCL), and anti-beta2-glycopr

30 A, C, B/B', and D, for anti-U1 RNA, and for anticardiolipin antibodies (aCL).

31 had lupus anticoagulant and/or high titer of anticardiolipin antibodies (aCL).

32 d lupus anticoagulant (LA) or high titers of anticardiolipin antibodies (ACLAs), either immunoglobuli

33 Anticardiolipin antibodies (antiCl), present in some pat

34 nt with acute Q fever and high levels of IgG anticardiolipin antibodies (IgG aCL).

35 Anticardiolipin antibodies and anti-beta2GPI were presen

36 otein(a), homocysteine, lupus anticoagulant, anticardiolipin antibodies and genotyping of factor V Le

37 f CL is needed to generate epitopes for many anticardiolipin antibodies and that some of these epitop

38 Anticardiolipin antibodies appeared from 7.6 years prior

39 Our findings indicate that anticardiolipin antibodies are frequently elevated in pa

40 We recently suggested that many anticardiolipin antibodies bind only to oxidized cardiol

41 relationship between dyslipoproteinemia and anticardiolipin antibodies has been demonstrated.

42 and technical complications, but the role of anticardiolipin antibodies has not been evaluated.

43 Lupus anticoagulants and anticardiolipin antibodies have been strongly associated

44 strated that human monoclonal and polyclonal anticardiolipin antibodies have thrombogenic properties

45 ted the possible association between HAT and anticardiolipin antibodies in adult patients who underwe

46 Other potential consequences of anticardiolipin antibodies in end-stage liver disease re

47 Anticardiolipin antibodies in SLE patients tend to prece

48 ity for lupus anticoagulant (P < 0.0001) and anticardiolipin antibodies of the IgG (P = 0.035) or the

49 Determination of IgM and IgG anticardiolipin antibodies was performed by enzyme-linke

50 iciency, activated protein C resistance, and anticardiolipin antibodies) at predictably greater risk

51 atients with stroke associated with elevated anticardiolipin antibodies, and we discuss their managem

52 Ls were measured longitudinally: 3 in serum (anticardiolipin antibodies, beta2-glycoprotein I, and an

53 nd 1 patient each with protein C deficiency, anticardiolipin antibodies, factor VII mutation, factor

54 Anticardiolipin antibodies, found at elevated serum conc

55 luded if they had moderate or high levels of anticardiolipin antibodies, lupus anticoagulant, or a hi

56 of Raynaud's phenomenon, as well as elevated anticardiolipin antibodies, lupus anticoagulant, or a hi

57 e not generalizable to women with high-titer anticardiolipin antibodies, lupus anticoagulant, or prev

58 Antiphospholipid antibodies including anticardiolipin antibodies, lupus anticoagulants, and an

59 and the presence of the lupus anticoagulant, anticardiolipin antibodies, or anti-beta(2)-glycoprotein

60 include measurements of lupus anticoagulant, anticardiolipin antibodies, thyroid function, and a tran

61 coagulable state associated with circulating anticardiolipin antibodies, which prompted discontinuati

62 ding; and those who had detectable levels of anticardiolipin antibodies.

63 fetal loss in a mouse pregnancy model due to anticardiolipin antibodies.

64 , thrombin, APC, and plasmin, as well as for anticardiolipin antibody (aCL) activity.

65 rotein AI to OxCL-coated wells increased the anticardiolipin antibody (aCL) binding from APS sera tha

66 uble-stranded DNA (anti-dsDNA) antibody, and anticardiolipin antibody (aCL), as well as proteinuria a

67 La, anti-RNP, lupus anticoagulant (LAC), and anticardiolipin antibody [aCL]) were selected for cluste

68 of 35 (63%) liver recipients had a positive anticardiolipin antibody test (either IgG or IgM titer >

69 either the lupus anticoagulant titer or the anticardiolipin antibody titer on two occasions, separat

70 ng anticoagulant therapy in patients with an anticardiolipin antibody was 1.53 (95% CI, 0.76-3.11), a

71 ter IgG or IgM anticardiolipin antibody, IgA anticardiolipin antibody, and anti-beta2-glycoprotein I

72 aris, thrombocytopenia, low-titer IgG or IgM anticardiolipin antibody, IgA anticardiolipin antibody,

73 in lymphocyte count or serum immunoglobulin, anticardiolipin antibody, or rubella IgG antibody concen

74 Reactive antibodies to lupus anticoagulant, anticardiolipin, antithrombin III, and the translational

75 IgG and IgM aCL were measured using an anticardiolipin assay.

76 beta2-glycoprotein I (beta2GPI)-dependent anticardiolipin autoantibodies (aCl) are associated with

77 protective effect against the production of anticardiolipin autoantibodies (Ptrend=1.6x10(-4), ORhig

78 pholipid antibodies (aPL) were identified by anticardiolipin enzyme-linked immunosorbent assay (ELISA

79 In the present study, we observed that IgG anticardiolipin from periodontitis subjects also causes

80 We observed that anticardiolipin from periodontitis subjects competes for

81 In addition, we found that anticardiolipin from periodontitis subjects increases an

82 ntibodies were present(defined as IgG or IgM anticardiolipin > or =40 IU/ml or the presence of lupus

83 lness significantly correlated with elevated anticardiolipin IgA (sdCOVID and scCOVID, P < .001), ant

84 Furthermore, human anticardiolipin IgG is associated with increased serum m

85 iolipin IgA (sdCOVID and scCOVID, P < .001), anticardiolipin IgM (sdCOVID, P = .003; scCOVID, P< .001

86 Being positive for anticardiolipin immunoglobulin M antibodies was a risk f

87 gG from periodontitis subjects with elevated anticardiolipin levels may influence pregnancy outcomes

88 antigens, such as cathepsin G, elastase, and anticardiolipin, may also be detected in some patients.

89 Activation of the trophoblastic cells by anticardiolipin occurs through Toll-like receptor 4.

90 Patients with only low titer anticardiolipin or anti-beta(2)-glycoprotein I antibodie

91 holipid antibodies and persistently positive anticardiolipin or lupus anticoagulant positive tests.

92 ant treatment at baseline, or positivity for anticardiolipin- or anti-beta2-glycoprotein I antibodies

93 ed from periodontitis subjects with elevated anticardiolipin stimulates inflammatory cytokine product

94 s with HAT also tended to have a higher mean anticardiolipin titer of IgG and IgM and a lower pretran

95 rmed by annexin V on trophoblast surfaces by anticardiolipin, via its interaction with its target ant